A.M.A. Archives of Internal Medicine
Author :
Publisher :
Page : 1072 pages
File Size : 34,34 MB
Release : 1959
Category : Internal medicine
ISBN :
Author :
Publisher :
Page : 1072 pages
File Size : 34,34 MB
Release : 1959
Category : Internal medicine
ISBN :
Author : Benjamin Frank Miller
Publisher :
Page : 658 pages
File Size : 40,38 MB
Release : 1967
Category : Hygiene
ISBN :
Author : American Medical Association
Publisher :
Page : 72 pages
File Size : 27,47 MB
Release : 1919
Category : Authorship
ISBN :
Author :
Publisher :
Page : 128 pages
File Size : 36,54 MB
Release : 1958
Category : Energy development
ISBN :
Author : National Institutes of Health (U.S.)
Publisher :
Page : 124 pages
File Size : 18,87 MB
Release : 1960
Category : Biochemistry
ISBN :
Presents the broad outline of NIH organizational structure, theprofessional staff, and their scientific and technical publications covering work done at NIH.
Author : J. A. McCormick
Publisher :
Page : 132 pages
File Size : 30,71 MB
Release : 1960
Category : Nuclear medicine
ISBN :
Author :
Publisher :
Page : 542 pages
File Size : 38,26 MB
Release : 1959
Category : Medicine
ISBN :
Includes section, "Recent book acquisitions" (varies: Recent United States publications) formerly published separately by the U.S. Army Medical Library.
Author : J. A. McCormick
Publisher :
Page : 32 pages
File Size : 35,66 MB
Release : 1959
Category : Radioisotopes
ISBN :
Author : United States. Congress. Senate. Committee on the Judiciary
Publisher :
Page : 940 pages
File Size : 40,42 MB
Release : 1961
Category : Antitrust law
ISBN :
Author : United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher :
Page : 1182 pages
File Size : 25,77 MB
Release : 1961
Category : Antitrust law
ISBN :
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.